Literature DB >> 19858003

Topoisomerase IIalpha-dependent induction of a persistent DNA damage response in response to transient etoposide exposure.

Sébastien Soubeyrand1, Louise Pope, Robert J G Haché.   

Abstract

Cytotoxicity of the topoisomerase II (topoII) poison etoposide has been ascribed to the persistent covalent trapping of topoII in DNA cleavage complexes that become lethal as cells replicate their DNA. However, short term etoposide treatment also leads to subsequent cell death, suggesting that the lesions that lead to cytotoxicity arise rapidly and prior to the onset DNA replication. In the present study 1h treatment with 25muM etoposide was highly toxic and initiated a double-stranded DNA damage response as reflected by the recruitment of ATM, MDC1 and DNA-PKcs to gammaH2AX foci. While most DNA breaks were rapidly repaired upon withdrawal of the etoposide treatment, the repair machinery remained engaged in foci for at least 24h following withdrawal. TopoII siRNA ablation showed the etoposide toxicity and gammaH2AX response to correlate with the inability of the cell to correct topoIIalpha-initiated DNA damage. gammaH2AX induction was resistant to the inhibition of DNA replication and transcription, but was increased by pre-treatment with the histone deacetylase inhibitor trichostatin A. These results link the lethality of etoposide to the generation of persistent topoIIalpha-dependent DNA defects within topologically open chromatin domains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858003      PMCID: PMC5527959          DOI: 10.1016/j.molonc.2009.09.003

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  56 in total

1.  A protease pathway for the repair of topoisomerase II-DNA covalent complexes.

Authors:  Ailing Zhang; Yi Lisa Lyu; Chao-Po Lin; Nai Zhou; Anna M Azarova; Laurence M Wood; Leroy F Liu
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

2.  A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery.

Authors:  Michael-Christopher Keogh; Jung-Ae Kim; Michael Downey; Jeffrey Fillingham; Dipanjan Chowdhury; Jacob C Harrison; Megumi Onishi; Nira Datta; Sarah Galicia; Andrew Emili; Judy Lieberman; Xuetong Shen; Stephen Buratowski; James E Haber; Daniel Durocher; Jack F Greenblatt; Nevan J Krogan
Journal:  Nature       Date:  2005-11-20       Impact factor: 49.962

3.  A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.

Authors:  Bong-Gun Ju; Victoria V Lunyak; Valentina Perissi; Ivan Garcia-Bassets; David W Rose; Christopher K Glass; Michael G Rosenfeld
Journal:  Science       Date:  2006-06-23       Impact factor: 47.728

4.  Assembly of nuclear matrix-bound protein complexes involved in non-homologous end joining is induced by inhibition of DNA topoisomerase II.

Authors:  Omar L Kantidze; Olga V Iarovaia; Sergey V Razin
Journal:  J Cell Physiol       Date:  2006-06       Impact factor: 6.384

Review 5.  Topoisomerase-targeting antitumor drugs.

Authors:  P D'Arpa; L F Liu
Journal:  Biochim Biophys Acta       Date:  1989-12-17

Review 6.  DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide.

Authors:  P B Jensen; M Sehested
Journal:  Biochem Pharmacol       Date:  1997-10-01       Impact factor: 5.858

7.  Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase.

Authors:  Toshiki Tanaka; H Dorota Halicka; Frank Traganos; Karen Seiter; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2007-02-09       Impact factor: 4.534

8.  Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses.

Authors:  Jia-Rong Fan; An-Lin Peng; Hsiang-Chin Chen; Shu-Chi Lo; Ting-Hsiang Huang; Tsai-Kun Li
Journal:  DNA Repair (Amst)       Date:  2008-03-01

9.  NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.

Authors:  Eriko Toyoda; Shigehide Kagaya; Ian G Cowell; Aya Kurosawa; Keiichi Kamoshita; Kiyohiro Nishikawa; Susumu Iiizumi; Hideki Koyama; Caroline A Austin; Noritaka Adachi
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

10.  Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells.

Authors:  C Hennequin; N Giocanti; J Balosso; V Favaudon
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

View more
  18 in total

1.  Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II.

Authors:  Xia Xue; Xian-Jun Qu; Zu-Hua Gao; Cui-Cui Sun; Hui-Ping Liu; Cui-Rong Zhao; Yan-Na Cheng; Hong-Xiang Lou
Journal:  Invest New Drugs       Date:  2010-10-06       Impact factor: 3.850

2.  Reduced DNA double-strand break repair capacity and risk of squamous cell carcinoma of the head and neck--A case-control study.

Authors:  Zhensheng Liu; Hongliang Liu; Fengqin Gao; Kristina R Dahlstrom; Erich M Sturgis; Qingyi Wei
Journal:  DNA Repair (Amst)       Date:  2016-03-02

3.  Nol12 is a multifunctional RNA binding protein at the nexus of RNA and DNA metabolism.

Authors:  Daniel D Scott; Christian Trahan; Pierre J Zindy; Lisbeth C Aguilar; Marc Y Delubac; Eric L Van Nostrand; Srivathsan Adivarahan; Karen E Wei; Gene W Yeo; Daniel Zenklusen; Marlene Oeffinger
Journal:  Nucleic Acids Res       Date:  2017-12-01       Impact factor: 16.971

4.  Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?

Authors:  H Sevim; J F Parkinson; K L McDonald
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-09       Impact factor: 4.553

5.  Radiation Sensitivity and Tumor Susceptibility in ATM Phospho-Mutant ATF2 Mice.

Authors:  Shuangwei Li; Sergei Ezhevsky; Antimone Dewing; Matthew H Cato; Marzia Scortegagna; Anindita Bhoumik; Wolfgang Breitwieser; Demetrious Braddock; Alexey Eroshkin; Jianfei Qi; Meifan Chen; Jae-Young Kim; Stephen Jones; Nic Jones; Robert Rickert; Ze'ev A Ronai
Journal:  Genes Cancer       Date:  2010-04-01

6.  p38 MAPK inhibits nonsense-mediated RNA decay in response to persistent DNA damage in noncycling cells.

Authors:  Andrew Nickless; Abigael Cheruiyot; Kevin C Flanagan; David Piwnica-Worms; Sheila A Stewart; Zhongsheng You
Journal:  J Biol Chem       Date:  2017-08-01       Impact factor: 5.157

7.  Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.

Authors:  Stéphane Vispé; Arthur Deroide; Emeline Davoine; Cécile Desjobert; Fabrice Lestienne; Lucie Fournier; Natacha Novosad; Sophie Bréand; Jérôme Besse; Florence Busato; Jörg Tost; Luc De Vries; Didier Cussac; Joëlle Riond; Paola B Arimondo
Journal:  Oncotarget       Date:  2015-06-20

8.  Gerosuppression in confluent cells.

Authors:  Olga V Leontieva; Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2014-12       Impact factor: 5.682

9.  miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin.

Authors:  Nibedita Patel; Koteswara Rao Garikapati; Raj K Pandita; Dharmendra Kumar Singh; Tej K Pandita; Utpal Bhadra; Manika Pal Bhadra
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

10.  Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells.

Authors:  Charmina Aguirre-Alvarado; Aldo Segura-Cabrera; Inés Velázquez-Quesada; Miguel A Hernández-Esquivel; Carlos A García-Pérez; Sandra L Guerrero-Rodríguez; Angel J Ruiz-Moreno; Andrea Rodríguez-Moreno; Sonia M Pérez-Tapia; Marco A Velasco-Velázquez
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.